Heska Corp (HSKA) Receives $51.00 Consensus Price Target from Brokerages
Heska Corp (NASDAQ:HSKA) has been given a consensus rating of “Buy” by the six brokerages that are presently covering the firm. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $51.00.
HSKA has been the topic of a number of recent research reports. Sidoti initiated coverage on Heska Corp in a research note on Friday, July 1st. They issued a “buy” rating and a $49.00 target price on the stock. Zacks Investment Research cut Heska Corp from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 5th. B. Riley reissued a “buy” rating and issued a $42.50 target price on shares of Heska Corp in a research note on Monday, August 1st. Finally, Gabelli cut Heska Corp from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th.
In other news, CFO Jason A. Napolitano sold 5,000 shares of the stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $52.53, for a total value of $262,650.00. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Kevin S. Wilson sold 20,000 shares of the stock in a transaction on Monday, August 29th. The stock was sold at an average price of $51.80, for a total value of $1,036,000.00. Following the completion of the sale, the chief executive officer now directly owns 110,000 shares in the company, valued at $5,698,000. The disclosure for this sale can be found here. 15.30% of the stock is owned by insiders.
Large investors have recently added to or reduced their stakes in the company. Prudential Financial Inc. boosted its stake in Heska Corp by 229.6% in the first quarter. Prudential Financial Inc. now owns 22,250 shares of the company’s stock worth $634,000 after buying an additional 15,500 shares in the last quarter. Landscape Capital Management L.L.C. bought a new stake in Heska Corp during the first quarter worth approximately $251,000. State Street Corp boosted its stake in Heska Corp by 7.9% in the first quarter. State Street Corp now owns 84,363 shares of the company’s stock worth $2,406,000 after buying an additional 6,170 shares in the last quarter. Geode Capital Management LLC boosted its stake in Heska Corp by 17.1% in the first quarter. Geode Capital Management LLC now owns 41,447 shares of the company’s stock worth $1,181,000 after buying an additional 6,051 shares in the last quarter. Finally, Acadian Asset Management LLC boosted its stake in Heska Corp by 21.5% in the second quarter. Acadian Asset Management LLC now owns 102,804 shares of the company’s stock worth $3,821,000 after buying an additional 18,211 shares in the last quarter. 68.32% of the stock is currently owned by hedge funds and other institutional investors.
Shares of Heska Corp (NASDAQ:HSKA) opened at 53.32 on Wednesday. Heska Corp has a one year low of $26.25 and a one year high of $57.41. The company has a 50-day moving average price of $54.33 and a 200 day moving average price of $42.12. The stock has a market cap of $366.58 million, a price-to-earnings ratio of 54.02 and a beta of 0.41.
Heska Corp (NASDAQ:HSKA) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.18 by $0.17. The company had revenue of $30 million for the quarter, compared to analysts’ expectations of $28.47 million. Heska Corp had a return on equity of 8.75% and a net margin of 6.22%. The firm’s revenue was up 25.5% on a year-over-year basis. Equities research analysts expect that Heska Corp will post $1.12 earnings per share for the current year.
About Heska Corp
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.
Receive News & Ratings for Heska Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska Corp and related companies with MarketBeat.com's FREE daily email newsletter.